Towa Pharmaceutical , Ltd. Profit Margin

Towa Pharmaceutical , Ltd.'s profit margin stands at 2.93% as of June 2026. That compares with 6.1% in the prior-year period — down 51.9% year over year. That is below the sector sector average of 13.16%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Towa Pharmaceutical , Ltd. reported 2.93% in profit margin versus 6.1% a year earlier — a 51.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Towa Pharmaceutical , Ltd. sits lower the its sector benchmark (13.16%) with a profit margin of 2.93%. That is roughly 77.7% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 2.93% for Towa Pharmaceutical , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Towa Pharmaceutical , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places TWAPF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.